statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND...

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES PR Newswire MINNEAPOLIS, May 31, 2024 MINNEAPOLIS, May 31, 2024 /PRNewswire...

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS CONFERENCE

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS CONFERENCE BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS...

ScaleReady Announces $20 Million G-Rex Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing

ScaleReady Announces $20 Million G-Rex Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing ScaleReady Announces $20 Million G-Rex Grant Program for the...

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE

BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE PR Newswire MINNEAPOLIS, May...

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY

BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE...

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024

BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 PR Newswire MINNEAPOLIS, May 8, 2024 MINNEAPOLIS, May...

BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)

BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY...

S&P 500 Gains and Losses Today: CVS Falls as Health Care Costs Pressure Profits

Investopedia

 Key TakeawaysThe S&P 500 fell 0.3% on Wednesday, May 1, 2024, as the Federal Reserve held interest rates steady and Chair Jerome Powell discounted the likelihood of an imminent rate...

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS PR Newswire MINNEAPOLIS, May 1, 2024 MINNEAPOLIS, May 1, 2024 /PRNewswire/ -- Bio-Techne...

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Volume	969,063.00
52-Wk High	$85.85
52-Wk Low	$51.79

TECH Bio-Techne Corp

About

Feed

News

Sentiment

Earnings

Fundamentals